Pathophysiology of Heart Failure and an Overview of Therapies

J. M. Berthiaume, J. A. Kirk, M. J. Ranek, R. C. Lyon, F. Sheikh, B. C. Jensen, B. D. Hoit, Jagdish Butany, M. Tolend, V. Rao, Monte Willis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Heart failure (HF) is a highly complex clinical syndrome, culminating from a diversity of environmental and genetic etiologies that compromise pump function, ultimately resulting in insufficient blood flow to the body. Despite the initial disease in the heart, the pathophysiology of HF evolves to affect multiple organ systems throughout the body, primarily the renal, autonomic, vascular, and cardiac system. The structural and functional underpinnings of HF are diverse and accompanied by various cellular changes that compromised cardiomyocyte function and survival to alter cardiac tissue. The progressive nature of HF and an expanding understanding of the intracellular molecular and biochemical changes that accompany this condition has allowed for the development of both surgical and pharmacological approaches to therapeutic management of HF. This chapter provides an overview of the contemporary knowledge regarding HF, spanning physiology to molecular events in the cardiomyocyte, and current therapeutic approaches used in the clinic.

Original languageEnglish (US)
Title of host publicationCardiovascular Pathology
Subtitle of host publicationFourth Edition
PublisherElsevier Inc.
Pages271-339
Number of pages69
ISBN (Electronic)9780128004593
ISBN (Print)9780124202191
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Heart Failure
Cardiac Myocytes
Therapeutics
Blood Vessels
Heart Diseases
Pharmacology
Kidney

Keywords

  • Cardiac dysfunction
  • Cardiomyocyte
  • Cell signaling
  • Energetics
  • Heart failure
  • Myocardial remodeling
  • Neurohormonal
  • Pathological hypertrophy
  • Pump function
  • Ventricular assist device

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Berthiaume, J. M., Kirk, J. A., Ranek, M. J., Lyon, R. C., Sheikh, F., Jensen, B. C., ... Willis, M. (2015). Pathophysiology of Heart Failure and an Overview of Therapies. In Cardiovascular Pathology: Fourth Edition (pp. 271-339). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-420219-1.00008-2

Pathophysiology of Heart Failure and an Overview of Therapies. / Berthiaume, J. M.; Kirk, J. A.; Ranek, M. J.; Lyon, R. C.; Sheikh, F.; Jensen, B. C.; Hoit, B. D.; Butany, Jagdish; Tolend, M.; Rao, V.; Willis, Monte.

Cardiovascular Pathology: Fourth Edition. Elsevier Inc., 2015. p. 271-339.

Research output: Chapter in Book/Report/Conference proceedingChapter

Berthiaume, JM, Kirk, JA, Ranek, MJ, Lyon, RC, Sheikh, F, Jensen, BC, Hoit, BD, Butany, J, Tolend, M, Rao, V & Willis, M 2015, Pathophysiology of Heart Failure and an Overview of Therapies. in Cardiovascular Pathology: Fourth Edition. Elsevier Inc., pp. 271-339. https://doi.org/10.1016/B978-0-12-420219-1.00008-2
Berthiaume JM, Kirk JA, Ranek MJ, Lyon RC, Sheikh F, Jensen BC et al. Pathophysiology of Heart Failure and an Overview of Therapies. In Cardiovascular Pathology: Fourth Edition. Elsevier Inc. 2015. p. 271-339 https://doi.org/10.1016/B978-0-12-420219-1.00008-2
Berthiaume, J. M. ; Kirk, J. A. ; Ranek, M. J. ; Lyon, R. C. ; Sheikh, F. ; Jensen, B. C. ; Hoit, B. D. ; Butany, Jagdish ; Tolend, M. ; Rao, V. ; Willis, Monte. / Pathophysiology of Heart Failure and an Overview of Therapies. Cardiovascular Pathology: Fourth Edition. Elsevier Inc., 2015. pp. 271-339
@inbook{69ad3ea7f4634d0fb204d571a2935df8,
title = "Pathophysiology of Heart Failure and an Overview of Therapies",
abstract = "Heart failure (HF) is a highly complex clinical syndrome, culminating from a diversity of environmental and genetic etiologies that compromise pump function, ultimately resulting in insufficient blood flow to the body. Despite the initial disease in the heart, the pathophysiology of HF evolves to affect multiple organ systems throughout the body, primarily the renal, autonomic, vascular, and cardiac system. The structural and functional underpinnings of HF are diverse and accompanied by various cellular changes that compromised cardiomyocyte function and survival to alter cardiac tissue. The progressive nature of HF and an expanding understanding of the intracellular molecular and biochemical changes that accompany this condition has allowed for the development of both surgical and pharmacological approaches to therapeutic management of HF. This chapter provides an overview of the contemporary knowledge regarding HF, spanning physiology to molecular events in the cardiomyocyte, and current therapeutic approaches used in the clinic.",
keywords = "Cardiac dysfunction, Cardiomyocyte, Cell signaling, Energetics, Heart failure, Myocardial remodeling, Neurohormonal, Pathological hypertrophy, Pump function, Ventricular assist device",
author = "Berthiaume, {J. M.} and Kirk, {J. A.} and Ranek, {M. J.} and Lyon, {R. C.} and F. Sheikh and Jensen, {B. C.} and Hoit, {B. D.} and Jagdish Butany and M. Tolend and V. Rao and Monte Willis",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-420219-1.00008-2",
language = "English (US)",
isbn = "9780124202191",
pages = "271--339",
booktitle = "Cardiovascular Pathology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Pathophysiology of Heart Failure and an Overview of Therapies

AU - Berthiaume, J. M.

AU - Kirk, J. A.

AU - Ranek, M. J.

AU - Lyon, R. C.

AU - Sheikh, F.

AU - Jensen, B. C.

AU - Hoit, B. D.

AU - Butany, Jagdish

AU - Tolend, M.

AU - Rao, V.

AU - Willis, Monte

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Heart failure (HF) is a highly complex clinical syndrome, culminating from a diversity of environmental and genetic etiologies that compromise pump function, ultimately resulting in insufficient blood flow to the body. Despite the initial disease in the heart, the pathophysiology of HF evolves to affect multiple organ systems throughout the body, primarily the renal, autonomic, vascular, and cardiac system. The structural and functional underpinnings of HF are diverse and accompanied by various cellular changes that compromised cardiomyocyte function and survival to alter cardiac tissue. The progressive nature of HF and an expanding understanding of the intracellular molecular and biochemical changes that accompany this condition has allowed for the development of both surgical and pharmacological approaches to therapeutic management of HF. This chapter provides an overview of the contemporary knowledge regarding HF, spanning physiology to molecular events in the cardiomyocyte, and current therapeutic approaches used in the clinic.

AB - Heart failure (HF) is a highly complex clinical syndrome, culminating from a diversity of environmental and genetic etiologies that compromise pump function, ultimately resulting in insufficient blood flow to the body. Despite the initial disease in the heart, the pathophysiology of HF evolves to affect multiple organ systems throughout the body, primarily the renal, autonomic, vascular, and cardiac system. The structural and functional underpinnings of HF are diverse and accompanied by various cellular changes that compromised cardiomyocyte function and survival to alter cardiac tissue. The progressive nature of HF and an expanding understanding of the intracellular molecular and biochemical changes that accompany this condition has allowed for the development of both surgical and pharmacological approaches to therapeutic management of HF. This chapter provides an overview of the contemporary knowledge regarding HF, spanning physiology to molecular events in the cardiomyocyte, and current therapeutic approaches used in the clinic.

KW - Cardiac dysfunction

KW - Cardiomyocyte

KW - Cell signaling

KW - Energetics

KW - Heart failure

KW - Myocardial remodeling

KW - Neurohormonal

KW - Pathological hypertrophy

KW - Pump function

KW - Ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=85007569936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007569936&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-420219-1.00008-2

DO - 10.1016/B978-0-12-420219-1.00008-2

M3 - Chapter

AN - SCOPUS:85007569936

SN - 9780124202191

SP - 271

EP - 339

BT - Cardiovascular Pathology

PB - Elsevier Inc.

ER -